Picture of Prostatype Genomics AB logo

PROGEN Prostatype Genomics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Prostatype Genomics Gets CAP Laboratory Accreditation

Feb 9 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * RECEIVES CAP LABORATORY ACCREDITATION, ACHIEVES ANOTHER
MILESTONE TOWARDS ENTERING THE US MARKET
    * IN DISCUSSIONS WITH AMERICAN UROLOGISTS INTERESTED IN
USING
PROSTATYPE TESTING SERVICE WHEN IT BECOMES COMMERCIALLY
AVAILABLE

Source text for Eikon:  ID:nWkr6trFyz 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Prostatype Genomics AB

See all news